Study aims to restore patient's ejection fraction through prophylactic use of Impella during a non-emergent PCI (ProPCI). Study hypothesizes that the use of ProPCI leads to a significant improvement of the patients left ventricular ejection fraction (LVEF) through the course of study.

The primary objective of this study is to assess the patient's LVEF at 90 days post-ProPCI as assessed in routine clinical practice and collected from EHR by clinical investigators. The prophylactic use of Impella 2.5 or CP heart pumps during a non-emergent PCI in hemodynamically stable patients at high-risk for periprocedural complications during the procedure is associated with a significant improvement in the patients LVEF and clinical status. This multi center, prospective, observational, non-interventional single arm, study of intermediate-term clinical outcomes collects patient data from EHR of high-risk patients which have previously undergone standard of care prophylactic Impella support for a non-emergent PCI.

Scholars @ ECU